Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Engineering Lactobacillus rhamnosus GG and GR-1 to express HIV-inhibiting griffithsin.

Petrova MI, van den Broek MFL, Spacova I, Verhoeven TLA, Balzarini J, Vanderleyden J, Schols D, Lebeer S.

Int J Antimicrob Agents. 2018 Nov;52(5):599-607. doi: 10.1016/j.ijantimicag.2018.07.013. Epub 2018 Jul 21.

PMID:
30040991
2.

Multifactorial inhibition of lactobacilli against the respiratory tract pathogen Moraxella catarrhalis.

van den Broek MFL, De Boeck I, Claes IJJ, Nizet V, Lebeer S.

Benef Microbes. 2018 Apr 25;9(3):429-439. doi: 10.3920/BM2017.0101. Epub 2018 Apr 10.

PMID:
29633637
3.

Comparing the Healthy Nose and Nasopharynx Microbiota Reveals Continuity As Well As Niche-Specificity.

De Boeck I, Wittouck S, Wuyts S, Oerlemans EFM, van den Broek MFL, Vandenheuvel D, Vanderveken O, Lebeer S.

Front Microbiol. 2017 Nov 29;8:2372. doi: 10.3389/fmicb.2017.02372. eCollection 2017.

4.

Enhancing the viability of Lactobacillus rhamnosus GG after spray drying and during storage.

Broeckx G, Vandenheuvel D, Henkens T, Kiekens S, van den Broek MFL, Lebeer S, Kiekens F.

Int J Pharm. 2017 Dec 20;534(1-2):35-41. doi: 10.1016/j.ijpharm.2017.09.075. Epub 2017 Oct 3.

PMID:
28986319
5.

Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides.

Allonsius CN, van den Broek MFL, De Boeck I, Kiekens S, Oerlemans EFM, Kiekens F, Foubert K, Vandenheuvel D, Cos P, Delputte P, Lebeer S.

Microb Biotechnol. 2017 Nov;10(6):1753-1763. doi: 10.1111/1751-7915.12799. Epub 2017 Aug 3.

6.

Electromagnetic-guided placement of nasoduodenal feeding tubes versus endoscopic placement: a randomized, multicenter trial.

Kappelle WFW, Walter D, Stadhouders PH, Jebbink HJA, Vleggaar FP, van der Schaar PJ, Kappelle JW, van der Tweel I, Van den Broek MFM, Wessels FJ, Siersema PD, Monkelbaan JF.

Gastrointest Endosc. 2018 Jan;87(1):110-118. doi: 10.1016/j.gie.2017.05.033. Epub 2017 Jun 1.

PMID:
28579349
7.

Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients.

de Laat JM, Pieterman CR, van den Broek MF, Twisk JW, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, Valk GD.

J Clin Endocrinol Metab. 2014 Sep;99(9):3325-33. doi: 10.1210/jc.2014-1560. Epub 2014 Jun 10.

PMID:
24915123
8.

No evidence for distinguishing bacterial from viral acute rhinosinusitis using symptom duration and purulent rhinorrhea: a systematic review of the evidence base.

van den Broek MF, Gudden C, Kluijfhout WP, Stam-Slob MC, Aarts MC, Kaper NM, van der Heijden GJ.

Otolaryngol Head Neck Surg. 2014 Apr;150(4):533-7. doi: 10.1177/0194599814522595. Epub 2014 Feb 10. Review.

PMID:
24515968
9.

Seasonal and meteorological determinants of aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

de Steenhuijsen Piters WA, Algra A, van den Broek MF, Dorhout Mees SM, Rinkel GJ.

J Neurol. 2013 Feb;260(2):614-9. doi: 10.1007/s00415-012-6687-z. Epub 2012 Oct 16. Review.

PMID:
23070464
10.

Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHC.

Martinic MM, van den Broek MF, Rülicke T, Huber C, Odermatt B, Reith W, Horvath E, Zellweger R, Fink K, Recher M, Eschli B, Hengartner H, Zinkernagel RM.

Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14435-40. Epub 2006 Sep 18.

11.

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression.

Probst HC, Tschannen K, Gallimore A, Martinic M, Basler M, Dumrese T, Jones E, van den Broek MF.

J Immunol. 2003 Nov 15;171(10):5415-22.

12.
13.

The role of perforin in infections and tumour surveillance.

van den Broek MF, Hengartner H.

Exp Physiol. 2000 Nov;85(6):681-5. Review.

PMID:
11187963
14.
15.

Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.

Binder D, van den Broek MF, Kägi D, Bluethmann H, Fehr J, Hengartner H, Zinkernagel RM.

J Exp Med. 1998 Jun 1;187(11):1903-20.

16.

Effector pathways of natural killer cells.

Van den Broek MF, Kägi D, Hengartner H.

Curr Top Microbiol Immunol. 1998;230:123-31. Review. No abstract available.

PMID:
9586354
17.

Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.

van den Broek MF, Spörri R, Even C, Plagemann PG, Hänseler E, Hengartner H, Zinkernagel RM.

J Immunol. 1997 Aug 15;159(4):1585-8.

PMID:
9257815
18.

On the interaction between agalactosyl IgG and Fc gamma receptors.

Groenink J, Spijker J, van den Herik-Oudijk IE, Boeije L, Rook G, Aarden L, Smeenk R, van de Winkel JG, van den Broek MF.

Eur J Immunol. 1996 Jun;26(6):1404-7.

PMID:
8647224
19.

Immune defence in mice lacking type I and/or type II interferon receptors.

van den Broek MF, Müller U, Huang S, Zinkernagel RM, Aguet M.

Immunol Rev. 1995 Dec;148:5-18. Review.

PMID:
8825279
20.

Perforin dependence of natural killer cell-mediated tumor control in vivo.

van den Broek MF, Kägi D, Zinkernagel RM, Hengartner H.

Eur J Immunol. 1995 Dec;25(12):3514-6.

PMID:
8566046
21.

Susceptibility to Plasmodium berghei infection in rats is modulated by the acute phase response.

Vreden SG, Van den Broek MF, Oettinger MC, Boers W, Van-Rooijen N, Meuwissen JH, Sauerwein RW.

Parasite Immunol. 1995 Sep;17(9):445-50.

PMID:
8552412
22.

Inhibition of Plasmodium berghei liver schizont development and reduction of cytokine production capacity in rats by dietary fish oil supplementation.

Vreden SG, Blok WL, Sauerwein RW, Oettinger MC, Verhave JP, Meuwissen JE, Van der Meer JW, Van den Broek MF.

Am J Trop Med Hyg. 1995 Aug;53(2):206-10.

PMID:
7677226
23.

Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors.

van den Broek MF, Müller U, Huang S, Aguet M, Zinkernagel RM.

J Virol. 1995 Aug;69(8):4792-6.

24.

Kupffer cell elimination enhances development of liver schizonts of Plasmodium berghei in rats.

Vreden SG, Sauerwein RW, Verhave JP, Van Rooijen N, Meuwissen JH, Van Den Broek MF.

Infect Immun. 1993 May;61(5):1936-9.

25.

Immunomodulation of streptococcal cell wall-induced arthritis. Identification of inflammatory cells and regulatory T cell subsets by mercuric chloride and in vivo CD8 depletion.

van den Broek MF, de Heer E, van Bruggen MC, de Roo G, Kleiverda K, Eulderink F, van den Berg WB.

Eur J Immunol. 1992 Dec;22(12):3091-5.

PMID:
1446702
26.

Cytokines inhibit the development of liver schizonts of the malaria parasite Plasmodium berghei in vivo.

Vreden SG, van den Broek MF, Oettinger MC, Verhave JP, Meuwissen JH, Sauerwein RW.

Eur J Immunol. 1992 Sep;22(9):2271-5.

PMID:
1516619
27.

Gut flora induces and maintains resistance against streptococcal cell wall-induced arthritis in F344 rats.

van den Broek MF, van Bruggen MC, Koopman JP, Hazenberg MP, van den Berg WB.

Clin Exp Immunol. 1992 May;88(2):313-7.

28.

Treatment of rats with monoclonal anti-CD4 induces long-term resistance to streptococcal cell wall-induced arthritis.

Van den Broek MF, Van de Langerijt LG, Van Bruggen MC, Billingham ME, Van den Berg WB.

Eur J Immunol. 1992 Jan;22(1):57-61.

PMID:
1730259
29.

Streptococcal cell wall-induced arthritis and adjuvant arthritis in F344----Lewis and in Lewis----F344 bone marrow chimeras.

van Bruggen MC, van den Broek MF, van den Berg WB.

Cell Immunol. 1991 Sep;136(2):278-90.

PMID:
1873821
30.

Flare-up reaction of streptococcal cell wall induced arthritis in Lewis and F344 rats: the role of T lymphocytes.

van den Broek MF, van Bruggen MC, Stimpson SA, Severijnen AJ, van de Putte LB, van den Berg WB.

Clin Exp Immunol. 1990 Feb;79(2):297-306.

31.
32.

Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein.

van den Broek MF, Hogervorst EJ, Van Bruggen MC, Van Eden W, van der Zee R, van den Berg WB.

J Exp Med. 1989 Aug 1;170(2):449-66.

33.

T cell responses to streptococcal antigens in rats: relation to susceptibility to streptococcal cell wall-induced arthritis.

van den Broek MF, van Bruggen MC, van de Putte LB, van den Berg WB.

Cell Immunol. 1988 Oct 1;116(1):216-29.

PMID:
3262429
34.

Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell walls.

van den Broek MF, van den Berg WB, van de Putte LB, Severijnen AJ.

Am J Pathol. 1988 Oct;133(1):139-49.

35.

Stimulation of antigen-specific murine T cell clones in vitro with antigen-pulsed adherent cells fixed to a carrier.

Van den Elsen JH, Van den Broek MF, Klasen IS, Van den Berg WB.

J Immunol Methods. 1988 Aug 9;112(1):15-22.

PMID:
2457053
36.

Crohn's disease associated with arthritis: a possible role for cross-reactivity between gut bacteria and cartilage in the pathogenesis of arthritis.

Van den Broek MF, Van de Putte LB, Van den Berg WB.

Arthritis Rheum. 1988 Aug;31(8):1077-9. No abstract available.

PMID:
3408509
37.

Reaction of bacterium-primed murine T cells to cartilage components: a clue for the pathogenesis of arthritis?

van den Broek MF, van den Berg WB, Arntz OJ, van de Putte LB.

Clin Exp Immunol. 1988 Apr;72(1):9-14.

38.

The role of mast cells in antigen induced arthritis in mice.

van den Broek MF, van den Berg WB, van de Putte LB.

J Rheumatol. 1988 Apr;15(4):544-51.

PMID:
2456387
39.

The role of antigen electric charge in the development of chronic arthritis.

van Lent PL, van den Berg WB, van den Broek MF, van de Putte LB.

Agents Actions. 1986 Dec;19(5-6):326-7. No abstract available.

PMID:
3825750
40.

The role of MHC class II antigens in the flare up reaction of antigen-induced arthritis in mice.

van den Broek MF, van den Berg WB, van de Putte LB.

Agents Actions. 1986 Dec;19(5-6):328-30. No abstract available.

PMID:
3469892
41.

Monoclonal anti-Ia antibodies suppress the flare up reaction of antigen induced arthritis in mice.

van den Broek MF, van den Berg WB, van de Putte LB.

Clin Exp Immunol. 1986 Nov;66(2):320-30.

Supplemental Content

Loading ...
Support Center